Altered expression of E-cadherin in hepatocellular carcinoma: Correlations with genetic alterations, β-catenin expression, and clinical features

Hepatology

Volumn 36, Issue 3, 2002, Pages 692-701

  Wei, Yu ^a   Van Nhieu, Jeanne Tran ^b   Prigent, Sylvie ^a   Srivatanakul, Petcharin ^c   Tiollais, Pierre ^a   Buendia, Marie Annick ^a  

^a INSTITUT PASTEUR   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c NATIONAL CANCER INSTITUTE   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; UVOMORULIN; WNT PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 0036725378     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.35342     Document Type: Article

References (53)

1. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization
2. Comprehensive allelotyping of human hepatocellular carcinoma
3. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis
4. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma
5. Genetics of hepatocellular carcinoma
6. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas
7. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1
8. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma
9. Deletion mapping of chromosome 16q in hepatocellular carcinoma
10. Identification of a 1-Mb common region at 16q24.1-24.2 deleted in hepatocellular carcinoma
11. Identification of homozygous deletions at chromosome 16q23 in Aflatoxin B1 exposed hepatocellular carcinoma
12. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinoma
13. Expression of cadherins and alpha-catenin in primary epithelial tumors of the liver
14. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinoma
15. Frequent down-regulation of E-cadherin by genetic and epigenetic changes in the malignant progression of hepatocellular carcinomas
16. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion
17. Cell-cell contacts mediated by E-cadherin (uvomorulin) restrict invasive behavior of L-cells
18. E-cadherin-dependent growth suppression is mediated by the cyclin-dependent kinase inhibitor p27(KIP1)
19. E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner
20. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation
21. Inhibition of beta-catenin-mediated transactivation by cadherin derivatives
22. E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity
23. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers
24. Mutations of the human Ecadherin (CDH1) gene
25. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells
26. The E-cadherin/catenin complex: An important gatekeeper in breast cancer tumorigenesis and malignant progression
27. Methylation patterns of the E-cadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression
28. Identification of the familial cylindromatosis tumour-suppressor gene
29. An intact overexpressed E-cadherin/alpha, beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma
30. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma
31. Histological typing of tumors of the liver
32. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation
33. Assignment of E-cadherin (CDH1) and KSP-cadherin (CDH16) to chromosome 16q22.1 by radiation hybrid mapping
34. E-cadherin germline mutations in familial gastric cancer
35. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas
36. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
37. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation
38. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas
39. E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration
40. E-cadherin promotes intraepithelial expansion of bladder carcinoma cells in an in vitro model of carcinoma in situ
41. Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma
42. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma
43. Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma: Association with elevated alpha-fetoprotein production
44. Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: Correlation with HBV and HCV infections and cellular proliferation rate
45. Comprehensive allelotype study of hepatocellular carcinoma: Potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and-negative tumors
46. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
47. Mechanisms of inactivation of E-cadherin in breast carcinoma: Modification of the two-hit hypothesis of tumor suppressor gene
48. Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: A key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion
49. Inverse correlation between E-cadherin and Snail expression in hepatocellular carcinoma cell lines in vitro and in vivo
50. Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex
51. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2
52. The oncogenic activation of beta-catenin
53. Close correlation between β-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas